Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • Specialties
  • Page 194
Weekend Warrior Exercise Patterns: Comparable Cardiometabolic Protection to Regular Activity in Diabetes and MASLD
Posted inClinical Updates Diabetes & Endocrinology news Specialties

Weekend Warrior Exercise Patterns: Comparable Cardiometabolic Protection to Regular Activity in Diabetes and MASLD

Posted by MedXY By MedXY 07/31/2025
Accumulating 150 minutes of moderate-to-vigorous physical activity weekly, either as a 'weekend warrior' or in regular sessions, significantly reduces mortality and cardiometabolic risk in adults with diabetes and MASLD.
Read More
GLP-1 Receptor Agonists and Dementia Risk in Older Adults With Type 2 Diabetes: Insights From a Target Trial Emulation
Posted inClinical Updates Diabetes & Endocrinology news Specialties

GLP-1 Receptor Agonists and Dementia Risk in Older Adults With Type 2 Diabetes: Insights From a Target Trial Emulation

Posted by MedXY By MedXY 07/31/2025
A large-scale emulated trial found no clear overall reduction in dementia risk with GLP-1 receptor agonists versus DPP-4 inhibitors in older adults with type 2 diabetes, though age-specific effects warrant further investigation.
Read More
Medial Opening Wedge High Tibial Osteotomy for Medial Compartment Knee Osteoarthritis: Evidence from a Randomized Controlled Trial
Posted inClinical Updates Medical News Orthopedics Specialties

Medial Opening Wedge High Tibial Osteotomy for Medial Compartment Knee Osteoarthritis: Evidence from a Randomized Controlled Trial

Posted by MedXY By MedXY 07/31/2025
A randomized trial demonstrates that medial opening wedge high tibial osteotomy (HTO) slows cartilage loss and improves symptoms in patients with medial compartment knee osteoarthritis and varus alignment, supporting its role as a joint-preserving intervention.
Read More
Rituximab Shows No Superiority Over Conventional Therapy for EGPA Remission Induction
Posted inClinical Updates news Rheumatology Specialties

Rituximab Shows No Superiority Over Conventional Therapy for EGPA Remission Induction

Posted by MedXY By MedXY 07/31/2025
A phase 3 randomized trial found rituximab no more effective than standard glucocorticoid-based therapy in inducing remission in eosinophilic granulomatosis with polyangiitis (EGPA), with comparable safety and relapse profiles.
Read More
Obesity-Linked Liver Cancer: A Preventable Crisis on the Rise
Posted inMedical News news Oncology Specialties

Obesity-Linked Liver Cancer: A Preventable Crisis on the Rise

Posted by MedXY By MedXY 07/31/2025
Over 60% of liver cancer cases are preventable, yet rising obesity and metabolic dysfunction threaten progress. The Lancet Commission outlines urgent strategies to curb a projected doubling of global liver cancer burden by 2050.
Read More
Preterm Birth Linked to Long-Term Adult Cardiometabolic and Mental Health Risks: New U.S. Cohort Study
Posted inCardiology Diabetes & Endocrinology Medical News news Specialties

Preterm Birth Linked to Long-Term Adult Cardiometabolic and Mental Health Risks: New U.S. Cohort Study

Posted by MedXY By MedXY 07/30/2025
Adults born preterm face significantly higher risks of cardiometabolic abnormalities and internalizing mental health problems by age 35, according to a new U.S. cohort study.
Read More
Understanding Adult Responses to Cannabis Health Warnings in US Recreational States: Insights from the EPPM Model
Posted inMedical News news Public Health Specialties

Understanding Adult Responses to Cannabis Health Warnings in US Recreational States: Insights from the EPPM Model

Posted by MedXY By MedXY 07/30/2025
A recent study reveals that most adults in US recreational states respond maladaptively to cannabis health warnings, highlighting challenges and opportunities for improved public health messaging.
Read More
Long-Term Fracture Risk After Menopausal Hormone Therapy: New Insights from a Landmark Study
Posted inClinical Updates news OB/GYN & Women's Health Specialties

Long-Term Fracture Risk After Menopausal Hormone Therapy: New Insights from a Landmark Study

Posted by MedXY By MedXY 07/30/2025
Large-scale UK data reveal a transient increase but sustained long-term reduction in fracture risk after discontinuing menopausal HRT, challenging prior assumptions and guiding future clinical decisions.
Read More
JAK Inhibitors and Venous Thromboembolism in Atopic Dermatitis: Clinical Risks and Practice Implications
Posted inClinical Updates Dermatology news Specialties

JAK Inhibitors and Venous Thromboembolism in Atopic Dermatitis: Clinical Risks and Practice Implications

Posted by MedXY By MedXY 07/30/2025
JAK inhibitors significantly increase the risk of venous thromboembolism compared to dupilumab and methotrexate in atopic dermatitis, underscoring the need for individualized risk stratification.
Read More
High Tibial Osteotomy May Slow Knee Osteoarthritis Progression in Bowlegged Patients: Clinical Insights from a Randomized Trial
Posted inClinical Updates Orthopedics Specialties

High Tibial Osteotomy May Slow Knee Osteoarthritis Progression in Bowlegged Patients: Clinical Insights from a Randomized Trial

Posted by MedXY By MedXY 07/30/2025
High tibial osteotomy (HTO) slows cartilage loss and improves pain and function in bowlegged patients with medial knee osteoarthritis compared to nonsurgical management, according to a new randomized trial.
Read More
FDA Approves Sephience: A New Oral Therapy for Phenylketonuria
Posted inInternal Medicine Medical News Pediatrics Specialties

FDA Approves Sephience: A New Oral Therapy for Phenylketonuria

Posted by MedXY By MedXY 07/30/2025
The FDA has approved Sephience, an oral therapy for phenylketonuria (PKU), offering a novel treatment option for both children and adults with this rare metabolic disorder.
Read More
EMA Recommends First Oral On-Demand Therapy for Hereditary Angioedema: A Paradigm Shift in Acute Attack Management
Posted inClinical Updates news Pediatrics Specialties

EMA Recommends First Oral On-Demand Therapy for Hereditary Angioedema: A Paradigm Shift in Acute Attack Management

Posted by MedXY By MedXY 07/30/2025
EMA endorses sebetralstat, the first oral on-demand therapy for hereditary angioedema, following positive results from the KONFIDENT phase 3 trial, offering a more convenient and rapid treatment option for acute attacks.
Read More
EMA Recommends Voranigo for IDH-Mutant Grade 2 Glioma: A New Era in Targeted Brain Tumor Therapy
Posted inClinical Updates news Oncology Specialties

EMA Recommends Voranigo for IDH-Mutant Grade 2 Glioma: A New Era in Targeted Brain Tumor Therapy

Posted by MedXY By MedXY 07/30/2025
The EMA’s CHMP recommends Voranigo, a dual IDH1/2 inhibitor, for grade 2 IDH-mutant gliomas, based on phase 3 INDIGO trial results demonstrating significant improvement in progression-free survival and delayed need for further therapy.
Read More
Parathyroidectomy Enhances Muscle Health in Postmenopausal Women with Primary Hyperparathyroidism
Posted inClinical Updates news OB/GYN & Women's Health Specialties

Parathyroidectomy Enhances Muscle Health in Postmenopausal Women with Primary Hyperparathyroidism

Posted by MedXY By MedXY 07/30/2025
Surgical treatment of primary hyperparathyroidism in postmenopausal women significantly improves muscle strength, volume, and metabolic pathways linked to exercise, without increased physical activity.
Read More
Unraveling the Drivers of Pruritus Severity in Intrahepatic Cholestasis of Pregnancy: Insights from a Longitudinal Cohort Study
Posted inClinical Updates Gastroenterology news Specialties

Unraveling the Drivers of Pruritus Severity in Intrahepatic Cholestasis of Pregnancy: Insights from a Longitudinal Cohort Study

Posted by MedXY By MedXY 07/30/2025
Peak bile acid levels and higher maternal BMI independently predict pruritus worsening in intrahepatic cholestasis of pregnancy, emphasizing the need for tailored monitoring and management as gestation advances.
Read More
Early Postoperative PTH as a Reliable Predictor of Hypoparathyroidism After Total Thyroidectomy
Posted inClinical Updates General Surgery news Specialties

Early Postoperative PTH as a Reliable Predictor of Hypoparathyroidism After Total Thyroidectomy

Posted by MedXY By MedXY 07/30/2025
A single parathyroid hormone (PTH) measurement 6 hours after total thyroidectomy can accurately predict the risk of transient and permanent hypoparathyroidism, enabling targeted monitoring and potential reduction in hospital stays.
Read More
Legacy of Leaded Gasoline: New Evidence Links Childhood and Adult Exposure to Cognitive Impairment in Older Adults
Posted inMedical News Neurology news Specialties

Legacy of Leaded Gasoline: New Evidence Links Childhood and Adult Exposure to Cognitive Impairment in Older Adults

Posted by MedXY By MedXY 07/30/2025
Recent studies confirm that both childhood and adult lead exposure, especially from gasoline and industrial sources, are associated with increased risk for cognitive decline and dementia in later life.
Read More
CDC Retracts Universal COVID-19 Vaccination Recommendation for Pregnancy: Clinical Context, Evidence, and Implications
Posted inMedical News news Public Health Specialties

CDC Retracts Universal COVID-19 Vaccination Recommendation for Pregnancy: Clinical Context, Evidence, and Implications

Posted by MedXY By MedXY 07/30/2025
The CDC no longer universally recommends COVID-19 vaccination during pregnancy, prompting debate among clinicians as the FDA shifts vaccine composition to target the JN.1 variant. This article analyzes the evidence, rationale, and clinical implications.
Read More
Is There a Norovirus Vaccine on the Horizon? Scientific Progress, Challenges, and Future Directions
Posted inGastroenterology Infectious Diseases Medical News news Pediatrics Specialties

Is There a Norovirus Vaccine on the Horizon? Scientific Progress, Challenges, and Future Directions

Posted by MedXY By MedXY 07/30/2025
Norovirus vaccines show promise in clinical trials, but scientific and logistical challenges remain. No approved vaccine exists yet, though novel approaches, including oral pills, are advancing development.
Read More
Expanding Access to Chronic Pain Care: Telehealth and Online CBT-Based Interventions Show Promise
Posted inClinical Updates news Orthopedics Specialties

Expanding Access to Chronic Pain Care: Telehealth and Online CBT-Based Interventions Show Promise

Posted by MedXY By MedXY 07/30/2025
Remote CBT-based interventions, delivered by telehealth or online modules, offer modest but significant improvements in pain and function for individuals with high-impact chronic pain, enhancing access to evidence-based care.
Read More

Posts pagination

Previous page 1 … 192 193 194 195 196 … 204 Next page
  • Persistent Risk of Cardiac Structural Complications in TAVR: A Decade-Long Analysis Reveals High Mortality and Stagnant Incidence
  • Insulin Resistance Blunts LVAD-Mediated Myocardial Recovery by Impairing the Pentose Phosphate Pathway
  • Beyond Peripheral Blood: Why Biopsy is the Gold Standard for Acute Eosinophilic Myocarditis
  • Daily Chlorhexidine Bathing in the ICU: Re-evaluating Infection Prevention and Antimicrobial Stewardship through the CLEAN-IT Trial
  • Daily Chlorhexidine Bathing in the ICU: Results from the CLEAN-IT Multicentre Trial
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular health cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology exercise health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality nutrition obesity older adults oncology Pediatrics Physical Activity precision medicine Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial SGLT2 inhibitors stroke targeted therapy type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in